Celgene Corporation:企業の戦略・SWOT・財務情報

◆英語タイトル:Celgene Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4436
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Celgene Corporation – Strategy, SWOT and Corporate Finance Report
Summary

Celgene Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Celgene Corporation (Celgene or ‘the company’) is an integrated biopharmaceutical company that is primarily involved in the research, development and marketing of novel therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. These are marketed under IMNOVID, REVLIMID, THALOMID and VIDAZA, to mention a few. It sells these products through wholesale distributors and specialty pharmacies in the US and its international sales are made directly to hospitals, clinics and retail chains, many of which are government owned. The company operates in the US, Europe and other countries. Celgene is headquartered in Summit, New Jersey, the US.

Scope

- Detailed information on Celgene Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Celgene Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Celgene Corporation including a breakdown and examination of key business segments
- Intelligence on Celgene Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Celgene Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Celgene Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Celgene Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Celgene Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Celgene Corporation: Company Overview 9
Celgene Corporation: Overview and Key Facts 9
Celgene Corporation: Overview 9
Celgene Corporation: Key Facts 9
Celgene Corporation: Key Employees 11
Celgene Corporation: Key Employee Biographies 12
Celgene Corporation: Major Products and Services 17
Celgene Corporation: Company History 19
Celgene Corporation: Management Statement 26
Celgene Corporation: Locations and Subsidiaries 30
Celgene Corporation: Key Competitors 32
Celgene Corporation: Company Analysis 33
Celgene Corporation: Business Description 33
Celgene Corporation: SWOT Analysis 35
Celgene Corporation: SWOT Overview 35
Celgene Corporation: Strengths 35
Celgene Corporation: Weaknesses 36
Celgene Corporation: Opportunities 36
Celgene Corporation: Threats 38
Celgene Corporation: Corporate Financial Deals Activity 39
Celgene Corporation: Financial Deals Overview 39
Celgene Corporation: Targets and Partners 41
Celgene Corporation: Top Deals 2014 – 2018YTD* 45
Celgene Corporation: Advisors 46
Celgene Corporation: Top Legal Advisors 46
Celgene Corporation: Top Financial Advisors 46
Celgene Corporation: Mergers and Acquisitions 48
Celgene Corporation: Corporate Venturing 49
Celgene Corporation: Capital Raising 50
Celgene Corporation: Partnership 51
Celgene Corporation: Recent Developments 52
Celgene Corporation: News and Events Summary 52
Celgene Corporation: Business Expansion 56
Celgene Corporation: Corporate Governance 56
Celgene Corporation: Financial Performance 57
Celgene Corporation: Market Developments 57
Celgene Corporation: Regulatory and Legal Events 59
Celgene Corporation: Strategy and Operations 60
Appendix 61
Contact Us 61
Methodology 61
About MarketLine 62

List of Tables
Table 1: Celgene Corporation: Key Facts
Table 2: Celgene Corporation: Key Employees
Table 3: Celgene Corporation: Locations and Subsidiaries
Table 4: Celgene Corporation: Key Competitors
Table 5: Celgene Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Celgene Corporation: M&A Activity by Geography (TTM*)
Table 7: Celgene Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Celgene Corporation: M&A Average Deal Size - Value (US$m)
Table 9: Celgene Corporation: Targets and Partners
Table 10: Celgene Corporation: Top Deals 2014 - 2018YTD*
Table 11: Celgene Corporation: Legal Advisor Ranking by Value (US$m)
Table 12: Celgene Corporation: Financial Advisor Ranking by Value (US$m)
Table 13: Celgene Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Celgene Corporation: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Celgene Corporation: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: Celgene Corporation: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: Celgene Corporation: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 18: Celgene Corporation: Capital Raising by Deal Type (2014 - YTD*2018)
Table 19: Celgene Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 20: Celgene Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 21: Celgene Corporation: News and Events Summary
Table 22: Celgene Corporation: Business Expansion
Table 23: Celgene Corporation: Corporate Governance
Table 24: Celgene Corporation: Financial Performance
Table 25: Celgene Corporation: Market Developments
Table 26: Celgene Corporation: Regulatory and Legal Events
Table 27: Celgene Corporation: Strategy and Operations

List of Figures
Figure 1: Celgene Corporation: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Celgene Corporation: M&A Activity by Geography (TTM*)
Figure 3: Celgene Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Celgene Corporation: M&A Average Deal Size - Value (US$m)
Figure 5: Celgene Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Celgene Corporation: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Celgene Corporation: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Celgene Corporation: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Celgene Corporation: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: Celgene Corporation: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: Celgene Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 12: Celgene Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Celgene Corporation:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • YTL Power International Berhad (YTLPOWR):企業の財務・戦略的SWOT分析
    YTL Power International Berhad (YTLPOWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Highland Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Highland Therapeutics Inc (Highland) is a pharmaceutical company that develops and commercializes novel drugs. The company utilizes delexis platform, a drug delivery technology that allows for the nighttime delivery of medicines to provide a delay in the initial release of the active drug, f …
  • BP Plc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    BP Plc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary BP Plc (BP) is an integrated oil and gas company. Its upstream activities include exploration, development and production of oil and natural gas, field development and production; and midstream operations inc …
  • Asda Stores Ltd:企業の戦略・SWOT・財務情報
    Asda Stores Ltd - Strategy, SWOT and Corporate Finance Report Summary Asda Stores Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Fresenius Medical Care AG & Co KGaA (FMS):医療機器:M&Aディール及び事業提携情報
    Summary Fresenius Medical Care AG & Co KGaA (Fresenius Medical), a subsidiary of Fresenius SE & Co KGaA, is an integrated dialysis company. It is one of the largest kidney dialysis companies in the world. It provides dialysis care services and products to individuals with chronic kidney failure. It …
  • Oglethorpe Power Corp:企業の戦略的SWOT分析
    Oglethorpe Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Celon Pharma SA (CLN):製薬・医療:M&Aディール及び事業提携情報
    Summary Celon Pharma SA (Celon Pharma), subsidiary of Glatton Sp zoo, is an integrated pharmaceutical company that carries out research and develops new medicines. The company provides product portfolio such as Aromek, Salmex, Valzek, Lazivir, Bosentan Celon, Donepex and Ketrel, among others. It pri …
  • Megapharm Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Megapharm Ltd (Megapharm) is a biotechnology company which offers marketing services. It is engaged in marketing of pharmaceutical products for international companies. Megapharm markets a wide range of products in various therapeutic areas such as dermatology, gastroenterology, central nerv …
  • Crrc Corporation Limited
    Crrc Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Crrc Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sartorius AG (SRT):医療機器:M&Aディール及び事業提携情報
    Summary Sartorius AG (Sartorius) manufactures and distributes laboratory and process technology equipment. The company’s lab products portfolio includes laboratory instruments, such as pipettes, laboratory water purification systems, weight sets and lab balances. It provides bioprocess solutions for …
  • PPC Limited:企業の戦略・SWOT・財務情報
    PPC Limited - Strategy, SWOT and Corporate Finance Report Summary PPC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Europ Assistance Holding SA:企業の戦略的SWOT分析
    Europ Assistance Holding SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Alfa Group Consortium:企業の戦略的SWOT分析
    Alfa Group Consortium - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Brainsway Ltd (BWAY):企業の製品パイプライン分析
    Summary Brainsway Ltd (Brainsway) is a medical device company that develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of neurological and psychopathological disorders. The company provides deep transcranial magnetic stimulation products. It of …
  • ALS Ltd (ALQ):企業の財務・戦略的SWOT分析
    ALS Ltd (ALQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Islandsbanki hf.:企業の戦略・SWOT・財務分析
    Islandsbanki hf. - Strategy, SWOT and Corporate Finance Report Summary Islandsbanki hf. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • The Binding Site Group Ltd:製品パイプライン分析
    Summary The Binding Site Group Ltd (Binding Site) is a clinical diagnostic tools supplier that concentrates on research, development, manufacturing and distribution of immunodiagnostic assays. The company’s product portfolio includes antibodies, antigens, bulk antisera, assays for plasma protein ana …
  • SolarWinds North America Inc:企業の戦略的SWOT分析
    SolarWinds North America Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • GateHouse Media, Inc.:企業のM&A・事業提携・投資動向
    GateHouse Media, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's GateHouse Media, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Telenet Group Holding NV:企業の戦略・SWOT・財務分析
    Telenet Group Holding NV - Strategy, SWOT and Corporate Finance Report Summary Telenet Group Holding NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆